TBIOTelesis Bio, Inc.

About Telesis Bio, Inc. (TBIO)

Telesis Bio, Inc. (TBIO) is a Medical Devices company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Pink tier.

Telesis Bio is a synthetic biology company enabling customers to rapidly, accurately and reproducibly build or "write" high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets.

Products and services

Synthetic biology.

TBIO key facts

Ticker symbol

TBIO

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

San Diego, CA, United States

Country of incorporation

US

Year of incorporation

2011

Employees

45

Estimated market cap

$29.00M (as of Apr 9, 2025)

Shares outstanding

78,390,766

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Oct 23, 2024)

Telesis Bio, Inc. leadership

• Eric Esser — CEO
• William Kullback — CFO
• Robert Cutler — General Counsel

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with T